Rankings
▼
Calendar
AQST
Aquestive Therapeutics, Inc.
$424M
Q2 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$11M
Gross Profit
$6M
53.9% margin
Operating Income
-$4M
-36.4% margin
Net Income
-$6M
-52.9% margin
EPS (Diluted)
$-0.29
QoQ Revenue Growth
-32.2%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$0
← FY 2017
All Quarters
Q3 2017 →
AQST Q2 2017 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
